“…In the last two decades, there has been an increasing interest in antibiosis by PGPB and such biocontrol mechanisms are now better understood [112]. Several metabolites with antibiotic nature produced by pseudomonads have been studied and characterized so far, e.g., the cyclic lipopeptide amphysin, 2,4diacetylphloroglucinol (DAPG), oomycin A, the aromatic polyketide pyoluteorin, pyrrolnitrin, the antibacterial compound tropolone [113,114]. Other bacterial genera, such as Bacillus, Streptomyces, Stenotrophomonas spp., produce the macrolide oligomycin A, kanosamine, the linear aminopolyol zwittermicin A, and xanthobactin [115,116].…”